VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PRGO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PRGOPerrigo Company plc
$11.19$1.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

PRGO logoPerrigo Company plc(PRGO)Earnings, Financials & Key Ratios

PRGO•NYSE
$11.19
Price updated Jul 7, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryConsumer health and OTC self-care
AboutPerrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.Show more
  • Revenue$4.25B-2.8%
  • EBITDA$681M+55.2%
  • Net Income-$1.43B-729.7%
  • EPS (Diluted)-10.29-723.2%
  • Gross Margin35.14%-0.4%
  • EBITDA Margin16.01%+59.5%
  • Operating Margin8.07%+212.7%
  • Net Margin-33.51%-753.2%
  • ROE-39.29%-939.2%

PRGO Price & Volume

Perrigo Company plc (PRGO) stock price & volume — 10-year historical chart

Loading chart...

Persistent Operational Headwinds Erode Equity Value

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Strained
Cash Flow:Deteriorating
Primary Risk:Eroding equity and leverage

Key Thesis Takeaways

  • Perrigo faces a challenging fundamental outlook characterized by consistent revenue contraction and significant earnings volatility that obscures underlying profitability.
  • The company's reliance on debt financing has intensified as equity has declined from $4.8 billion in 2023Q4 to $2.5 billion in 2026Q1, raising concerns regarding long-term capital structure sustainability.
  • Investors should monitor the company's ability to stabilize cash flows, as the current negative free cash flow margin of -13.1% and ongoing dividend commitments appear increasingly difficult to reconcile with its deteriorating liquidity position.

Verdict Logic

the company's fundamental profile is strained by a debt-to-equity ratio of 1.52 and a negative free cash flow margin of -13.1%, which suggests significant risk to shareholder value.

PRGO Growth Metrics

Perrigo Company plc (PRGO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-0.79%
5 Years0.79%
3 Years-1.51%
TTM-3.62%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-908.1%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-916.03%

Return on Capital

10 Years1.07%
5 Years2.46%
3 Years2.37%
Last Year4.26%

PRGO Recent Earnings

Perrigo Company plc (PRGO) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 3/12 qtrs (25%)
Q2 2026Latest
May 6, 2026
Metric
Actual
Est
EPS
$0.43+10.3%
$0.39
Rev
$969M-6.4%
$1.0B
Q1 2026
Feb 26, 2026
Metric
Actual
Est
EPS
$0.77-3.8%
$0.80
Rev
$1.1B+0.7%
$1.1B
Q4 2025
Nov 5, 2025
Metric
Actual
Est
EPS
$0.80+6.7%
$0.75
Rev
$1.0B-4.5%
$1.1B
Q3 2025
Aug 6, 2025
Metric
Actual
Est
EPS
$0.57-3.4%
$0.59
Rev
$1.1B-4.0%
$1.1B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 6, 2026
$0.43vs $0.39+10.3%
$969Mvs $1.0B-6.4%
Q1 2026Feb 26, 2026
$0.77vs $0.80-3.8%
$1.1Bvs $1.1B+0.7%
Q4 2025Nov 5, 2025
$0.80vs $0.75+6.7%
$1.0Bvs $1.1B-4.5%
Q3 2025Aug 6, 2025
$0.57vs $0.59-3.4%
$1.1Bvs $1.1B-4.0%
Based on last 12 quarters of dataView full earnings history →

Latest PRGO News

Recent stock market news and headlines for Perrigo Company plc (PRGO)

PRNewsWire·Jun 30, 2026
Perrigo Announces Appointment of Two New Independent Directors to Board

DUBLIN, June 30, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo"), a leading provider of consumer health products, today announced that its Board of Directors has appointed Salman Amin and Omer Gajial as independent directors, effective June 30, 2026. "We are pleased to welcome Salman and Omer to Perrigo's Board," said Orlando D.

Peers Comparison

Key metrics vs top competitors for Perrigo Company plc (PRGO)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
PRGO logoPRGOPerrigo Company plcCurrent
$11.19$1.55B-1.09-2.75%-33.51%-39.29%10.28%
HLN logoHLNHaleon plc
$9.84$43.82B20.41-3.96%14.46%19.9%—
CHGG logoCHGGChegg, Inc.
$0.94$105.11M-0.98-38.97%-26.89%-62.94%—
PBH logoPBHPrestige Consumer Healthcare Inc.
$50.42$2.39B12.90-4.31%17.48%10.29%—
CLAR logoCLARClarus Corporation
$3.18$122.24M-2.63-5.25%-17.67%-21.22%—
TEVA logoTEVATeva Pharmaceutical Industries Limited
$33.44$38.94B27.874.31%9.02%20.69%—

Compare PRGO vs Peers

Perrigo Company plc (PRGO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HLN

Most directly comparable listed peer for PRGO.

Scale Benchmark

vs JNJ

Larger-name benchmark to compare PRGO against a more recognizable public peer.

Peer Set

Compare Top 5

vs HLN, CHGG, PBH, CLAR

PRGO SEC Filings & Documents

Perrigo Company plc (PRGO) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 6, 2026·SEC

Material company update

May 5, 2026·SEC

Material company update

Apr 30, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 26, 2026·SEC

FY 2025

Feb 28, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

May 6, 2026·SEC

FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 6, 2025·SEC

Get notified when PRGO posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

PRGO Frequently Asked Questions

Perrigo Company plc (PRGO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Perrigo Company plc's revenue?

Perrigo Company plc (PRGO) reported $4.18B in revenue for fiscal year 2025. This represents a 437% increase from $778.1M in 1996.

How fast is Perrigo Company plc growing?

Perrigo Company plc (PRGO) saw revenue decline by 2.8% over the past year.

Is PRGO profitable?

Perrigo Company plc (PRGO) reported a net loss of $1.82B for fiscal year 2025.

Dividend & Returns
Does PRGO pay dividends?

Yes, Perrigo Company plc (PRGO) pays a dividend with a yield of 10.28%. This makes it attractive for income-focused investors.

What is PRGO's return on equity?

Perrigo Company plc (PRGO) has a return on equity (ROE) of -39.3%. Negative ROE indicates the company is unprofitable.

What is Perrigo Company plc's free cash flow?

Perrigo Company plc (PRGO) generated $107.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in PRGO back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →